Takara Bio Of Japan, U.S. University Join To Develop New HIV/AIDS Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Takara Bio and a U.S. university have signed a joint development agreement for a genetics-based HIV/AIDS treatment